Stock ME 23ANDME HOLDING CO.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus 23andMe Holding Co.

Equities

ME

US90138Q1085

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
0.4641 USD +1.11% Intraday chart for 23andMe Holding Co. -3.89% -49.20%
04-24 23andMe Holding Co. to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology Annual Meeting CI
04-23 Petros, Lemonaid Health Collaborate to Expand Stendra Availability MT

Evolution of the average Target Price on 23andMe Holding Co.

Price target over the last 5 years

History of analyst recommendation changes

fba.4g8I6zidz5NXnKw2P7bWePmmpsx1oTcdItMsrGkSt5U.qz1702n4t9gz-eVxbeeiSrT37oo_lllEdKZC6l5--typR0etAfj7xD3Y4Q~5a9ce2654a3f8706526304035738a3d0

Analyst Recommendations on 23andMe Holding Co.

23andMe CEO Mulls Plan to Take Company Private MT
Citigroup Adjusts 23andMe Price Target to $0.47 From $0.85, Maintains Neutral Rating MT
Citigroup Adjusts 23andMe Holding's Price Target to $1.75 From $2.50, Keeps Buy Rating MT
Citigroup Adjusts 23andMe Price Target to $2.50 From $3.75, Maintains Neutral Rating MT
Berenberg Bank Initiates Coverage on 23andMe Holding With Buy Rating, $7 Price Target MT
Credit Suisse Trims 23andMe Holding's Price Target to $6 From $7, Keeps Outperform Rating MT
Cowen Initiates Coverage on 23andMe With Outperform Rating, $6 Price Target MT
Credit Suisse Lowers 23andMe Holding's Price Target to $7 from $11, Notes Near-Term Consumer Volatility; Keeps Outperform Rating MT
Citigroup Adjusts Price Target on 23andMe to $3 From $6, Maintains Neutral Rating MT
Credit Suisse Lowers 23andMe Holding's PT to $11 from $14, Trims Revenue Multiple to Reflect Comparable Decline in Comps; Keeps Outperform Rating MT
Citigroup Adjusts Price Target on 23andMe Holding to $9 From $13, Maintains Neutral Rating MT
Citigroup Downgrades 23andMe to Neutral From Buy, Adjusts Price Target to $13 From $12 MT
CORRECTION : Credit Suisse Starts 23andMe Holding at Outperform with $13 PT MT
23andMe : Shares Soar After Credit Suisse Initiates Coverage with Outperform Rating MT
23ANDME : Credit Suisse Starts 23andMe Holding at Outperform with $31 PT, Sees Optionality for Therapeutics Segment Long Term; Trading Lower Pre-Market MT
23ANDME : Citigroup Starts 23andMe Holding at Buy with $14 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.4641 USD
Average target price
1.425 USD
Spread / Average Target
+207.05%
High Price Target
2 USD
Spread / Highest target
+330.94%
Low Price Target
0.85 USD
Spread / Lowest Target
+83.15%

Consensus detail

Consensus revision (last 18 months)

Analysts covering 23andMe Holding Co.

Citigroup
Berenberg Bank
Credit Suisse
Cowen

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ME Stock
  4. Consensus 23andMe Holding Co.